Abstract:Abstract Background Drug-disease associations (DDAs) can provide important information for exploring the potential efficacy of drugs. However, up to now, there are still few DDAs verified by experiments. Previous evidence indicates that the combination of information would be conducive to the discovery of new DDAs. How to integrate different biological data sources and identify the most effective drugs for a certain disease based on drug-disease coupled mechanisms is still a challenging problem. Results In this paper, we proposed a novel computation model for DDA predictions based on graph representation learning over multi-biomolecular network (GRLMN). More specifically, we firstly constructed a large-scale molecular association network (MAN) by integrating the associations among drugs, diseases, proteins, miRNAs, and lncRNAs. Then, a graph embedding model was used to learn vector representations for all drugs and diseases in MAN. Finally, the combined features were fed to a random forest (RF) model to predict new DDAs. The proposed model was evaluated on the SCMFDD-S data set using five-fold cross-validation. Experiment results showed that GRLMN model was very accurate with the area under the ROC curve (AUC) of 87.9%, which outperformed all previous works in terms of both accuracy and AUC in benchmark dataset. To further verify the high performance of GRLMN, we carried out two case studies for two common diseases. As a result, in the ranking of drugs that were predicted to be related to certain diseases (such as kidney disease and fever), 15 of the top 20 drugs have been experimentally confirmed. Conclusions The experimental results show that our model has good performance in the prediction of DDA. GRLMN is an effective prioritization tool for screening the reliable DDAs for follow-up studies concerning their participation in drug reposition.

REDDA: Integrating multiple biological relations to heterogeneous graph neural network for drug-disease association prediction

RANEDDI: Relation-aware Network Embedding for Drug-Drug Interaction Prediction

Attention-based Cross Domain Graph Neural Network for Prediction of Drug-Drug Interactions.

Relation-aware Heterogeneous Graph Transformer Based Drug Repurposing

Multi-level Subgraph Representation Learning for Drug-Disease Association Prediction over Heterogeneous Biological Information Network.

An effective drug-disease associations prediction model based on graphic representation learning over multi-biomolecular network

Gndd: A Graph Neural Network-Based Method For Drug-Disease Association Prediction

Drug-Disease Association Prediction Based on Neighborhood Information Aggregation in Neural Networks

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

Deep Multiple Instance Learning on Heterogeneous Graph for Drug-Disease Association Prediction.

Prediction of Drug-Disease Associations Based on Multi-Kernel Deep Learning Method in Heterogeneous Graph Embedding

Regulation-aware graph learning for drug repositioning over heterogeneous biological network

Graph-Based Neural Collaborative Filtering Model for Drug-Disease Associations Prediction

A Multi-graph Deep Learning Model for Predicting Drug-Disease Associations.

Predicting Potential Drug-Disease Associations Based on Hypergraph Learning with Subgraph Matching

Drug repositioning with adaptive graph convolutional networks

Drug-Disease Association Prediction Using Heterogeneous Networks for Computational Drug Repositioning

Drug repositioning based on the heterogeneous information fusion graph convolutional network

HGAlinker: Drug-Disease Association Prediction Based on Attention Mechanism of Heterogeneous Graph

NEDD: a Network Embedding Based Method for Predicting Drug-Disease Associations

GRTR: Drug-Disease Association Prediction Based on Graph Regularized Transductive Regression on Heterogeneous Network